Bromoindirubin-3-Oxime treatment enhances the in vitro proliferation and viability of rat marrow-derived mesenchymal stem cells

被引:0
|
作者
Eslaminejad, Mohamadreza Baghaban [1 ,3 ]
Salami, Farimah [2 ]
Mehranjani, Malek Soleymani [2 ]
Abnoosi, Mohammad Hossein [2 ]
Eftekhari-Yazdi, Poopak [3 ]
机构
[1] ACECR, Cell Sci Res Ctr, Royan Inst, Dept Stem Cell, Tehran, Iran
[2] Arak Univ, Dept Biol, Arak, Iran
[3] ACECR, Reprod Med Res Ctr, Royan Inst, Dept Embryol, Tehran, Iran
来源
PHYSIOLOGY AND PHARMACOLOGY | 2009年 / 13卷 / 01期
关键词
Mesenchymal stem cells; rat; BIO; proliferation;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Previous investigations have indicated that the presence of BIO (6-Bromoindirubin-3-Oxime) in the culture medium of some cell types enhances both cell proliferation and viability. The aim of the present study was to investigate the effect of BIO on rat marrow-derived mesenchymal stem cells (MSCs) expansion in culture. Methods: In the present experimental study, bone marrow cells from 7 rats were plated in the presence of 0.05, 0.01, 0.1, 1 and 1.5 mu M of BIO and expanded through 3 successive subcultures. During the cultivation period, the cultures were statistically compared in terms of indices of cell growth including the diameter and number of colonies, population doubling number (PDN) and the number of viable cells. Passaged-3 cells from all groups were examined for their differentiation capacity into bone and adipose cells. Results: According to our results, the largest colonies were formed in the cultures with 0.1 and 1 mu m BIO with diameters of 1262.27 +/- 43.96 and 1335.71 +/- 19.16 micrometer, respectively (P< 0.05). These 2 groups were also superior over other experimental and control groups in terms of colonies numbers. During 3 successive passages, significantly more PDN was occurred in 0.1 and 1 mu M BIO-treated cultures compared with other experimental and control groups (P< 0.05). Additionally, in these two BIO-treated cultures, the number of viable cells was significantly higher than that in other BIO-treated cultures as well as the control group (P< 0.05). Alizarin red staining for bone and oil red for adipose cells indicated that the cells from all studied groups maintained the differentiation potential into bone and adipose cells. Conclusion: Our findings indicate that the presence of BIO in marrow cell cultures enhances the in vitro cell expansion and viability.
引用
收藏
页码:57 / 67
页数:11
相关论文
共 50 条
  • [21] Bone marrow-derived mesenchymal stem cells for functional treatment of urinary incontinence in a rat model
    Feil, Gerhard
    Maurer, Sabine
    Moehle, Robert
    Seitz, Gabriele
    Krug, Jutta
    Bock, Conny
    Kanz, Lothar
    Stenzl, Arnulf
    Sievert, Karl-Dietrich
    TISSUE ENGINEERING, 2007, 13 (04): : 913 - 913
  • [22] Bone marrow-derived mesenchymal stem cells for functional treatment of urinary incontinence in a rat model
    Feil, G
    Boehmler, AM
    Maurer, S
    Zimmermann, R
    Seitz, G
    Stenzl, A
    Kanz, L
    Sievert, K
    Möhle, R
    BONE MARROW TRANSPLANTATION, 2006, 37 : S152 - S153
  • [23] Bone marrow-derived mesenchymal stem cells for treatment of experimental colitis
    Zuo, Dongmei
    Tang, Qing
    Fan, Heng
    Shou, Zhexing
    Liu, Xingxing
    Cao, Dan
    Zou, Zhou
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S117 - S117
  • [24] Bone marrow-derived mesenchymal stem cells for the treatment of heart failure
    Takuya Narita
    Ken Suzuki
    Heart Failure Reviews, 2015, 20 : 53 - 68
  • [25] Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
    Nakamizo, A
    Marini, F
    Amano, T
    Khan, A
    Studeny, M
    Gumin, J
    Chen, J
    Hentschel, S
    Vecil, G
    Dembinski, J
    Andreeff, M
    Lang, FF
    CANCER RESEARCH, 2005, 65 (08) : 3307 - 3318
  • [26] Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke
    Dharmasaroja, Permphan
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (01) : 12 - 20
  • [27] Bone marrow-derived mesenchymal stem cells for the treatment of heart failure
    Narita, Takuya
    Suzuki, Ken
    HEART FAILURE REVIEWS, 2015, 20 (01) : 53 - 68
  • [28] In vitro chondrogenic phenotype differentiation of bone marrow-derived mesenchymal stem cells
    Zhang Yufu
    Wang Changyong
    Liao Wen
    Li Zhanghua
    Guo Ximin
    Zhao Qiang
    Duan Cuimi
    Xia Renyun
    Current Medical Science, 2004, 24 (3) : 275 - 278
  • [29] Comparative study of in vitro expansion of bone marrow-derived mesenchymal stem cells
    Stefan Peter
    Andy M. Scutt
    Phillip C. Wright
    Catherine A. Biggs
    Biotechnology Letters, 2013, 35 : 463 - 469
  • [30] Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro
    Scherzed, A.
    Hackenberg, S.
    Froelich, K.
    Rak, K.
    Technau, A.
    Radeloff, A.
    Noeth, U.
    Koehler, C.
    Hagen, R.
    Kleinsasser, N.
    TOXICOLOGY LETTERS, 2013, 218 (03) : 207 - 214